Nanoscale · 2022 · 16 citations · 46 references
MedicineMolecular BiologyOncologyCarcinogenesisCell SignalingMolecular OncologyCancer BiomarkersCancer Cell SignalingCancer Molecular PathologyCell-cycle DysregulationMolecular Tumor ProfilingCancer BioinformaticsCancer Genomics DatabasesCell Cycle InhibitionG2/m Checkpoint ControlP53 Pathway AlterationsP53 Pathway DysregulationTumor Suppressor P53
< 0.001) in lung cancer tissues. We further found that PRKCSH deficiency promoted G2/M arrest in response to zinc oxide nanoparticle (Nano ZnO) treatment in A549 cells. With regard to the mechanism, PRKCSH deficiency may induce STAT6 translocation to the nucleus to activate p53 expression through binding to the p53 promoter region from -365 bp to +126 bp. Eventually, activated p53 contributed to Nano-ZnO-induced G2/M arrest in lung cancer cells. Taken together, our data provide new insights into immunotherapy target choices and the prognostic value of PRKCSH. Since the G2/M cell cycle checkpoint is crucial for lung cancer prognosis, targeting PRKCSH expression to suppress the activation of the STAT6/p53 pathway is a potential therapeutic strategy for managing lung cancer.
46
TIMER: A Web Server for Comprehensive Analysis of Tumor-Infiltrating Immune Cells
Taiwen Li, Jing‐Yu Fan, Binbin Wang et al. · Cancer Research · 2017 · 6.6K citations · Full text
Life Sciences, Immunology, Oncology +17
TIMER2.0 for analysis of tumor-infiltrating immune cells
Taiwen Li, Jingxin Fu, Zexian Zeng et al. · Nucleic Acids Research · 2020 · 5.7K citations · Full text
Medicine, Bioinformatics, Oncology +17
Peter Goldstraw, Kari Chansky, John Crowley et al. · Journal of Thoracic Oncology · 2016 · 4.6K citations · Full text
Preferential killing of cancer cells and activated human T cells using ZnO nanoparticles
Cory Hanley, Janet Layne, Alex Punnoose et al. · Nanotechnology · 2008 · 647 citations · Full text
Life Sciences, Immunology, Oncology +17
Suresh Senan, Anthony Brade, Lu-hua Wang et al. · Journal of Clinical Oncology · 2016 · 437 citations · Full text